-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZSVRTLv938Gtr5au4-6eYL
September 01, 2024 - of clinical trials and, for newer therapies, clini-
cal trial reports28,29; treatment efficacy (in the … dissemination Treatments and rates of use by time
period, ER/HER2, stage and age for
initial breast … therapy, and of newer targeted
therapies
Yes Yes; treatment effectiveness
reduced for Black patients … Dr Caswell-Jin reported receiving
grants from Novartis, Effector Therapeutics, and
QED Therapeutics outside … Dr Li reported holding stock in Agenus Inc and Mink
Therapeutics Inc outside the submitted work.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/depression-in-children-and-adolescents-screening
February 08, 2016 - For treatment of MDD, research needs include well-designed studies of psychotherapy and combined treatments … , as well as studies of the benefits and harms of other treatments (such as non-SSRI medications and … The current recommendation reaffirms these positions but removes the mention of specific therapies in … Recognising and responding to adolescent depression in general practice: developing and implementing the Therapeutic … Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol-2014.pdf
January 01, 2014 - However, the role of
diet in the etiology and treatment of gout is a topic of considerable research … A set of draft key questions encompassing both diagnosis and treatment of gout were
posted for public … relevant long-term outcomes (such as development of tophi, repeated flares that respond
to urate lowering therapies … Report of a task force of the Standing Committee for International
Clinical Studies Including Therapeutics … Primary care providers' knowledge, beliefs
and treatment practices for gout: results of a physician
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_disposition-comments.pdf
May 20, 2013 - WMC findings can influence management by changing
treatments. … WMC findings can influence management
by changing treatments. … can be used for treatment." … can be used for treatment." … TEP 6 Introduction On page 14, the list of potential therapies of constipation
is incomplete and does
-
psnet.ahrq.gov/node/72586/psn-pdf
December 23, 2020 - systems-approach
https://psnet.ahrq.gov//#1
https://psnet.ahrq.gov//#2
and should not influence other therapeutic … Nurses call doctors less often, care is escalated less frequently,
and doctors order fewer treatments … receiving team could have stated their understanding of the patient’s goals and which monitoring,
therapies … For this patient, the goal was to go home to a familiar environment, so for
example, therapies directed … Effect of ICU strain on timing of limitations in life-
sustaining therapy and on death.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pelvic-pain_executive.pdf
January 01, 2012 - • Pharmacologic agents
• Behavioral therapies
• Allied health
• CAMComorbidities
Treatment
Nonsurgical … Most
RCTs investigated hormone-based treatments for CPP. … Four RCTs examined nonpharmacologic
therapies—pelvic floor physical therapy, photographic-
enhanced counseling … Comparison of treatments for
pelvic congestion syndrome. … Add-back therapy
in the treatment of endometriosis-associated pain.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/gestational-diabetes-mellitus-screening-january-2014
January 14, 2014 - Treatment
Initial treatment includes moderate physical activity, dietary changes, support from diabetes … Benefits of Detection and Early Treatment
The USPSTF found adequate evidence that treatment of screen-detected … Treatment
Initial treatment includes moderate physical activity, dietary changes, support from diabetes … Additional studies are needed to evaluate the effect of different treatments for GDM on longer-term metabolic … Therapeutic Management, Delivery, and Postpartum Risk Assessment and Screening in Gestational Diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/patient-participant-generated-registries-guide-3rd-ed-addendum-white-paper.pdf
February 01, 2018 - guidelines and best practices, and contributed to the creation of a robust therapy development
pipeline … accelerated research undertaken by BioMarin as they
conducted a clinical trial of enzyme replacement therapy … disease in untreated patients, and allowed all children enrolled in the
trial to receive the active therapy … self-report data for duchenne
muscular dystrophy confirms natural history
and can be used to assess for therapeutic … Therapeutic
Innovation & Regulatory Science.
2014;48(5):574-82.
99.
-
www.ahrq.gov/prevention/guidelines/tobacco/clinicians/references/meta/index.html
October 01, 2014 - Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for … Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for … Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. … Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for … Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
January 01, 2011 - Accordingly, Medicare reimburses a major
share of total spending on cancer treatment, 45 percent of … marketplace.10 Further,
the development pipeline contains
numerous biologics that promise novel
anticancer therapies … The use of biologics in cancer therapy. US Pharmacist 2010;35(3)
(Oncology suppl):4-7.
10. … Novel agents on the horizon for cancer therapy.
CA Cancer J Clin 2009;59:111-137.
11. … Managing the expanded use of biologics across
therapeutic areas: an example from B-cell targeted therapies
-
www.ahrq.gov/sites/default/files/2024-01/kuo-report.pdf
January 01, 2024 - patient recruitment and
eligibility screening during an index visit; 2) phone assessment for medication therapy … interactions at the point of care (i.e., at the prescribing stage)
Failure to order appropriate toxic/therapeutic … for the insurance company, which
wastes time, because corrections must be made, so the initiation of therapy … Phase 2 Phone Assessment – The research fellow called patients and evaluated their
medication therapy … assistant and the research fellow reviewed patient charts
for information pertaining to medication therapy
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/Harris2001.pdf
January 01, 2001 - Often, compelling evidence that
screening tests and treatments can reduce morbidity
and mortality comes … and 2) uses a graphical format to
make explicit the populations, preventive services, di-
agnostic or therapeutic … (b) How do the efficacy and effectiveness of treatments
compare in community settings? … Even when good randomized
trials of therapeutic efficacy in asymptomatic patients
exist (e.g., therapy … How to use an article
about therapy or prevention. A. Are the results of the study valid?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-amendement.pdf
February 05, 2025 - ,16 dialectical behavioral therapy,15
family therapy,17, 18 attachment-based therapies, and variations … a) What are the components of effective psychosocial treatments (e.g., frequency or
intensity of therapy … and/or aspects of the therapeutic modality)? … or
integrative health
interventions (e.g., light
therapy, supplements)
Comparators • Treatment … as usual
• Another psychosocial intervention
• Another pharmacological therapy
• Combination therapies
-
hcup-us.ahrq.gov/db/nation/nis/reports/2004niscomparisonrpt.jsp
May 01, 2016 - The relationship between hospital size and treatment patterns is an example. … 20.42
20.02
Transplant Services 2 (pct)
7.17
7.28
Intensity Modulated Ray Radiation Therapy … inoculations
550 (60)
535 (28)
2.45 (0.05)
2.48 (0.20)
0.01 (0.00)
0.00** (0.00)
231: Other therapeutic … 0.03)
1.23
7.22 (0.14)
7.15
4.58 (0.15)
4.43
$47,118 (1,187)
$48,160
231: Other therapeutic … 0.01)
0.73*
8.07 (0.07)
8.18
7.83 (0.20)
7.95
$30,177 (777)
$30,665
213: Physical therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-grading-evidence_methods.pdf
November 01, 2013 - major depressive disorder who had
been treated with olanzapine, quetiapine, or risperidone as adjunct therapy … For example, EPCs can judge studies as consistent and find no meaningful difference
between treatments … For some treatments, data may be lacking about one or
more major outcome. … EPC systematic reviews have often focused on pharmaceutical therapies, for which both
efficacy and effectiveness … The principles behind the tactics
of performing therapeutic trials.
-
hcup-us.ahrq.gov/reports/statbriefs/sb239-Opioid-Payer-Hospital-Stays-ED-Visits-by-State.pdf
February 01, 2018 - • E935.0–E935.2: Heroin, methadone, other opiates and related narcotics causing adverse effects
in therapeutic … use
• E940.1: Opiate antagonists causing adverse effects in therapeutic use
It should be noted … However, if a patient received long-term care, rehabilitation,
or treatment for a psychiatric or chemical … However, if a patient received long-term care, rehabilitation, or treatment for a psychiatric or
chemical … quality of health
services, medical practice patterns, access to health care programs, and outcomes of treatments
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/inevidup.pdf
September 01, 2009 - needs that underlies treatment success. … Requiring a no-treatment or usual-treatment control con
dition may produce insurmountable barriers to … of the clinician–
patient relationship in terms of building trust and develop
ing a collaborative therapeutic … prevents, the burdens of
the therapy, the monetary costs of the therapy, and the
Current practice … Pharmacologic treatment of high blood pressure has side effects.
-
www.ahrq.gov/sites/default/files/2024-09/bickell-report.pdf
January 01, 2024 - Harvard Medical Practice
Study, and most of these errors were due to diagnostic mishaps, noninvasive therapeutic … mishaps, and delays in diagnosis and treatment (1). … In addition
to the data collected in the “Assessing the Variability in Time to Treatment in Surgery … These staff can hasten
the processes required for diagnosis and treatment. … Why do delays in treatment occur? Lessons learned from ruptured
appendicitis.
-
psnet.ahrq.gov/node/851568/psn-pdf
July 31, 2023 - ASAM recommends use of dexmedetomidine as an adjunct to
benzodiazepine therapy to control autonomic … who require mechanical
ventilation, have refractory AWS but are not candidates for other adjuvant therapies … Despite these mechanisms, which are helpful in AWS, it has a narrow therapeutic window and
important … less chance of readmission.35 FDA approved pharmacologic
treatments for alcohol use disorders include … ,
educated that AUD is a health condition with effective treatments, and provided with psychosocial
-
psnet.ahrq.gov/web-mm/complicated-course-severe-alcohol-withdrawal-dexmedetomidine-infusion
June 14, 2023 - For this reason, dexmedetomidine should almost always be used as adjunctive therapy with BZDs. 13 Propofol … AWS who require mechanical ventilation, have refractory AWS but are not candidates for other adjuvant therapies … Despite these mechanisms, which are helpful in AWS, it has a narrow therapeutic window and important … less chance of readmission. 35 FDA approved pharmacologic treatments for alcohol use disorders include … JAMA. 1997;278(2):144–151. [ Available at ] Detoxification and Substance Abuse Treatment (Treatment